Abstract
Cystic fibrosis (CF) is characterised by chronic airway inflammation. Pro-inflammatory mediators in the lung are regulated by the transcription factor nuclear factor kappa B (NFκB). We have assessed the effect of adenovirus and liposome-mediated overexpression of the NFκB inhibitor IκBα, as well as liposome-mediated transfection with oligonucleotides resembling NFκB consensus binding sites (decoys) in a cystic fibrosis airway epithelial cell line (CFTE). Electrophoretic mobility shift assays (EMSA) were used to assess NFκB activity and secretion of the pro-inflammatory cytokine interleukin-8 (IL-8) was measured by ELISA. At a MOI of 30, Ad-IκBα significantly decreased IL-8 secretion to 60% and 43% of control unstimulated and TNF-α stimulated cells, respectively. At this MOI, approximately 70% of cells are transduced. EMSA showed an approximately 50% decrease in NFκB activation. Liposome-mediated transfection of IκBα did not reduce IL-8 secretion, probably due to low transfection efficiency (approximately 5% of cells). Liposome-mediated transfection of CFTE cells with rhodamine-labeled decoy oligonucleotides indicated a transfection efficiency close to 100%. TNF-α stimulated IL-8 secretion was reduced by approximately 40% using this approach. EMSA confirmed a significant decrease of NFκB activation. Decoy oligonucleotides may be a promising approach for reduction of NFκB-mediated pulmonary inflammation.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Burnett D . Neutrophils. In: Stockely RA (ed) Pulmonary Defenses John Wiley: New York 1997 pp 113–127
Sibille Y, Reynolds HY . Macrophages and polymorphonuclear neutrophils in lung defense and injury Am Rev Resp Dis 1990 141: 471–501
Nadel JA . Protease actions on airway secretions. Relevance to cystic fibrosis Ann NY Acad Sci 1991 624: 286–296
Dean TP et al. Interleukin-8 concentrations are elevated in bronchoalveolar lavage, sputum, and sera of children with cystic fibrosis Pediatr Res 1993 34: 159–161
DiMango E, Zar HJ, Bryan R, Prince A . Diverse Pseudomonas aeruginosa gene products stimulate respiratory epithelial cells to produce interleukin-8 J Clin Invest 1995 96: 2204–2210
Scheid P et al. Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence (submitted for publication)
Baeuerle PA, Henkel T . Function and activation of NF-kappa B in the immune system Ann Rev Immunol 1994 12: 141–179
Barnes PJ, Karin M . Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases New Engl J Med 1997 336: 1066–1071
Grilli M, Chiu JJ, Lenardo MJ . NF-kappa B and Rel: participants in a multiform transcriptional regulatory system Int Rev Cytol 1993 143: 1–62
Schmitz ML, Baeuerle PA . The p65 subunit is responsible for the strong transcription activating potential of NF-kappa B EMBO J 1991 10: 3805–3817
Whiteside ST, Epinat JC, Rice NR, Israel A . I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity EMBO J 1997 16: 1413–1426
Brown K et al. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation Science 1995 267: 1485–1488
Traenckner EB, Wilk S, Baeuerle PA . A proteasome inhibitor prevents activation of NF-kappa B and stabilizes a newly phosphorylated form of I kappa B-alpha that is still bound to NF-kappa B EMBO J 1994 13: 5433–5441
Kunsch C, Rosen CA . NF-kappa B subunit-specific regulation of the interleukin-8 promoter Molec Cell Biol 1993 13: 6137–6146
DiMango E et al. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells J Clin Invest 1998 101: 2598–2605
Li JD et al. Activation of NF-kappaB via a Src-dependent Ras-MAPK-pp90rsk pathway is required for Pseudomonas aeruginosa-induced mucin overproduction in epithelial cells Proc Natl Acad Sci USA 1998 95: 5718–5723
Hart LA et al. Activation and localization of transcription factor, nuclear factor-kappaB, in asthma Am J Resp Crit Care Med 1998 158: 1585–1592
Lee JI, Burckart GJ . Nuclear factor kappa B: important transcription factor and therapeutic target J Clin Pharmacol 1998 38: 981–993
Tomita N et al. Transcription factor decoy for nuclear factor-kappa B inhibits tumor necrosis factor-alpha-induced expression of interleukin-6 and intracellular adhesion molecule-1 in endothelial cells J Hypertens 1998 16: 993–1000
Makarov SS et al. NF-kappa B as a target for anti-inflammatory gene therapy: suppression of inflammatory responses in monocytic and stromal cells by stable gene transfer of I kappa B alpha cDNA Gene Therapy 1997 4: 846–852
Wrighton CJ et al. Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor of the transcription factor NF-kappa B J Exp Med 1996 183: 1013–1022
Morishita R et al. In vivo transfection of cis element ‘decoy’ against nuclear factor-kappaB binding site prevents myocardial infarction Nature Med 1997 3: 894–899
Bohrer H et al. Role of NFkappaB in the mortality of sepsis J Clin Invest 1997 100: 972–985
Blackwell TS et al. In vivo antioxidant treatment suppresses nuclear factor kappa B activation and neutrophilic lung inflammation J Immunol 1996 157: 1630–1637
Becker S, Koren HS, Henke DC . Interleukin-8 expression in normal nasal epithelium and its modulation by infection with respiratory syncytial virus and cytokines tumor necrosis factor, interleukin-1, and interleukin-6 Am J Resp Cell Mol Biol 1993 8: 20–27
Marini M, Vittori E, Hollemborg J, Mattoli S . Expression of the potent inflammatory cytokines, granulocyte–macrophage colony-stimulating factor and interleukin-6 and interleukin-8, in bronchial epithelial cells of patients with asthma J Allerg Clin Immunol 1992 89: 1001–1009
Grubb BR et al. Inefficient gene transfer by adenovirus vector to cystic fibrosis airway epithelia of mice and humans Nature 1994 371: 802–806
Zabner J et al. Cellular and molecular barriers to gene transfer by a cationic lipid J Biol Chem 1995 270: 18997–19007
Kitson C et al. The extra- and intracellular barriers to lipid and adenovirus-mediated pulmonary gene transfer in native sheep airway epithelium Gene Therapy 1999 6: 534–546
Sorgi FL, Bhattacharya S, Huang L . Proteamine sulfate enhances lipid-mediated gene transfer Gene Therapy 1997 4: 961–968
Zelphati O, Liang XW, Hobart P, Felgner PL . Gene chemistry: functionally and conformationally intact fluorescent plasmid DNA Hum Gene Ther 1999 10: 15–24
Leonetti JP et al. Intracellular distribution of microinjected antisense oligonucleotides Proc Natl Acad Sci USA 1991 88: 2702–2706
Chin DJ et al. Rapid nuclear accumulation of injected oligodeoxyribonucleotides New Biol 1990 2: 1091–1100
Dean DA . Import of plasmid DNA into the nucleus is sequence specific Exp Cell Res 1997 230: 293–302
Kaplan JM et al. Potentiation of gene transfer to the mouse lung by complexes of adenovirus vector and polycations improves therapeutic potential Hum Gene Ther 1998 9: 1469–1479
Graham FL, Van der Eb AJ . A simple technique for the assay of infectivity of human adenovirus 5 DNA Virology 1973 52: 456–467
Traenckner EB et al. Phosphorylation of human I kappa B-alpha on serines 32 and 36 controls I kappa B-alpha proteolysis and NF-kappa B activation in response to diverse stimuli EMBO J 1995 142: 2876–2883
Sorgi FL, Huang L . Large scale production of DC-Chol cationic liposomes by microfluidization Int J Pharm 1996 144: 131–139
Pahl HL, Baeuerle PA . A novel signal transduction pathway from the endoplasmic reticulum to the nucleus is mediated by transcription factor NFkB EMBO J 1995 14: 2580–2588
Peterson GL . A simplification of the protein assay method of Lowry et al which is more generally applicable Anal Biochem 1977 83: 346–356
Davies JC et al. CFTR gene transfer reduces the binding of Pseudomonas aeruginosa to cystic fibrosis respiratory epithelium Am J Resp Cell Mol Biol 1997 16: 657–663
Lee ER et al. Detailed analysis of structures and formulations of cationic lipids for efficient gene transfer to the lung Hum Gene Ther 1996 7: 1701–1717
Acknowledgements
We thank Patrick Baeuerle for the IκBα cDNA, Judy St George for the Adeno-βgal, Ty Pitt for the Pseudomonas bacteria, Dieter Gruenert for the CFTE cells and Naruya Tomita for advice in using NFκB decoys. The study was funded by the Wellcome Trust, the Cystic Fibrosis Trust, by NIH grant DK44935 (LH) and a Wellcome Senior Clinical Fellowship (EWFWA).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Griesenbach, U., Scheid, P., Hillery, E. et al. Anti-inflammatory gene therapy directed at the airway epithelium. Gene Ther 7, 306–313 (2000). https://doi.org/10.1038/sj.gt.3301078
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3301078
Keywords
This article is cited by
-
Native matrix-based human lung alveolar tissue model in vitro: studies of the reparatory actions of mesenchymal stem cells
Cytotechnology (2017)
-
The effect of NF-κB antisense oligonucleotide on transdifferentiation of fibroblast in lung tissue of mice injured by bleomycin
Molecular Biology Reports (2014)
-
Antigen-Specific Peripheral Tolerance Induced by Topical Application of NF-κB Decoy Oligodeoxynucleotide
Journal of Investigative Dermatology (2006)
-
Intravenously administered oligonucleotides can be delivered to conducting airway epithelium via the bronchial circulation
Gene Therapy (2006)
-
Cytoplasmic deposition of NFκB decoy oligonucleotides is insufficient to inhibit bleomycin-induced pulmonary inflammation
Gene Therapy (2002)